Pancreatic neuroendocrine tumors: the basics, the gray zone, and the target

F1000Res. 2017 May 10:6:663. doi: 10.12688/f1000research.10188.1. eCollection 2017.

Abstract

Pancreatic neuroendocrine tumors (PanNETs) manifest with a range of symptoms and pose a therapeutic challenge. A team approach, in which many specialists come together, is necessary in the quest for the best patient-tailored treatment. Disciplines such as oncology, surgery, basic science, endocrinology, radiology, and nuclear medicine need to work side by side, equally contributing to patient care and to advancing our better understanding of this fascinating disease.

Keywords: islet cell tumours; panNETs; pancreatic neuroendocrine tumors.

Publication types

  • Review

Grants and funding

The author(s) declared that no grants were involved in supporting this work.